Update on surgical treatment for endometrial cancer

Expert Review of Anticancer Therapy

Volumn 5, Issue 1, 2005, Pages 113-121

  Juretzka, Margrit M ^a   Chi, Dennis S ^a   Sonoda, Yukio ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrial cancer; Laparoscopy; Minimally invasive surgery; Surgical cytoreduction; Surgical staging

Indexed keywords

ANTINEOPLASTIC AGENT; GESTAGEN;

ABDOMINAL HYSTERECTOMY; ADNEXA DISEASE; ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EARLY DIAGNOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; HIGH RISK PATIENT; HISTOPATHOLOGY; HOSPITAL COST; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; PELVIS EXENTERATION; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROPERITONEAL CANCER; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SYMPTOMATOLOGY; UTERINE CERVIX CANCER; UTERUS SURGERY; VAGINA CANCER; VAGINAL HYSTERECTOMY;

CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING;

EID: 14244268394     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.5.1.113     Document Type: Review

References (61)

1. American Cancer Society. Cancer Facts and Figures 2004. American Cancer Society, GA, USA (2004).
2. No authors listed. Classification and staging of malignant tumours in the female pelvis. Acta Obstet. Gynecol Scand. 50(1), 1-7 (1971).
3. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol. 40(1), 55-65 (1991).
4. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl.), 2035-2041 (1987).
5. Federation of Gynecology and Obstetrics. Corpus cancer staging. Int. J. Gynecol. Obstet. 28, 190 (1989).
6. Chan JK, Lin YG, Monk BJ, Tewari K, Bloss JD, Berman ML. Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet. Gynecol. 97(5 Pt 1), 707-711 (2001).
7. Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol. Oncol. 38(1), 46-48 (1990 ).
8. Franchi M, Ghezzi F, Melpignano M et al. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol. Oncol. 76(3), 357-361 (2000).
9. Altintas A, Cosar E, Vardar MA, Demir C, Tuncer I. Intraoperative assessment of depth of myometrial invasion in endometrial carcinoma. Eur. J. Gynecol. Oncol. 20(4), 329-331 (1999).
10. Doering DL, Barnhill DR, Weiser EB, Burke TW, Woodward JE, Park RC. Intraoperative evaluation of depth of myometrial invasion in Stage I endometrial adenocarcinoma. Obstet. Gynecol. 74(6), 930-933 (1989).
11. Barakat RR, Grigsby PW, Sabbatini P, Zaino RJ. Corpus-epithelial tumors. In: Principles and Practice of Gynecologic Oncology. Hoskins WJ, Perez CA, Young RC (Eds), Lippincott-Raven, PA, USA, 919-953 (1997).
12. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D&C and office endometrial biopsy in predicting Nal histopathologic grade in endometrial cancer. Obstet. Gynecol. 86(1), 38-42 (1995).
13. Obermair A, Geramou M, Gucer F et al. Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int. J. Gynecol. Cancer 9(5), 383-386 (1999).
14. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with Stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 355(9213), 1404-1411 (2000).
15. Keys HM, Roberts JA, Brunetto VL et al. A Phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92(3), 744-751 (2004).
16. Barnes MN, Roland PY, Straughn M et al. A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol. Oncol. 74(3), 443-447 (1999).
17. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer 91(2), 378-387 (2001).
18. Homesley HD, Boike G, Spiegel GW. Feasibility of laparoscopic management of presumed Stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a Gynecologic Oncology Group study. Int. J. Gynecol. Cancer 14(2), 341-347 (2004).
19. Kohler C, Klemm P, Schau A et al. Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies. Gynecol. Oncol. 95(1), 52-61 (2004).
20. Magrina JF, Mutone NF, Weaver AL, Magtibay PM, Fowler RS, Cornella JL. Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: morbidity and survival. Am. J. Obstet. Gynecol. 181(2), 376-381 (1999).
21. Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol. Oncol. 92(3), 789-793 (2004).
22. Gemignani ML, Curtin JP, Zelmanovich J, Patel DA, Venkatraman E, Barakat RR. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol. Oncol. 73(1), 5-11 (1999).
23. Malur S, Possover M, Schneider A. Laparoscopically assisted radical vaginal versus radical abdominal hysterectomy Type II in patients with cervical cancer. Surg. Endosc. 15(3), 289-292 (2001).
24. Fram KM. Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in Stage I endometrial cancer. Int. J. Gynecol. Cancer 12(1), 57-61 (2002).
25. Scribner DR Jr, Manuel RS, Walker JL, Johnson GA. Cost analysis of laparoscopy versus laparotomy for early endometrial cancer. Gynecol. Oncol. 75(3), 460-463 (1999).
26. Eltabbakh GH. Analysis of survival after laparoscopy in women with endometrial carcinoma. Cancer 95(9), 1894-1901 (2002).
27. Magrina JF, Weaver AL. Laparoscopic treatment of endometrial cancer: five-year recurrence and survival rates. Eur. J. Gynecol. Oncol. 25(4), 439-441 (2004).
28. Scribner DR Jr, Walker JL, Johnson GA, McMeekin DS, Gold MA, Mannel RS. Laparoscopic pelvic and paraaortic lymph node dissection in the obese. Gynecol. Oncol. 84(3), 426-430 (2002).
29. Scribner DR Jr, Walker JL, Johnson GA, McMeekin SD, Gold MA, Mannel RS. Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol. Oncol. 83(3), 563-568 (2001).
30. Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol. Oncol. 80(3), 378-382 (2001).
31. Vergote I, De Smet I, Amant F. Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol. Oncol. 84(3), 537-538 (2002).
32. Sonoda Y, Luken DW, Chi D et al. The significance of positive peritoneal cytology in clinical early-stage endometrial cancer patients treated by laparoscopically assisted vaginal hysterectomy. Proc. Soc. Gynecel. Oncol. (2001) (Abstract 1209).
33. Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Ovarian metastasis in endometrial carcinoma. Gynecol. Oncol. 70(2 , 183-187 (1998).
34. Connell PP, Rotmensch J, Waggoner S, Mundt AJ. The significance of adnexal involvement in endometrial carcinoma. Gynecol. Oncol. 74(1), 74-79 (1999).
35. Onda T, Yoshikawa H, Mizutani K et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br. J. Cancer 75(12), 1836-1841 (1997).
36. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol. Oncol. 76(3), 348-356 (2000).
37. Kilgore LC, Partridge EE, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56(1), 29-33 (1995).
38. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Moritz FJ. FIGO Stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer 13(5), 664-672 (2003).
39. Aalders JG, Abeler V, Kolstad P. Clinical (Stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients. Gynecol. Oncol. 17(1), 64-74 (1984).
40. Nicklin JL, Petersen RW. Stage 3B adenocarcinoma of the endometrium: a clinicopathologic study. Gynecol. Oncol. 78(2), 203-207 (2000).
41. Society of Gynecologic Oncologists Medical Practice Committee. Practice guidelines: uterine corpus-endometrial cancer. Society of Gynecologic Oncologists Medical Practice Committee. Oncology (Huntingt). 12(1), 122-126 (1998).
42. Mackillop WJ, Pringle JF. Stage III endometrial carcinoma. A review of 90 cases. Cancer 56(10), 2519-2523 (1985).
43. Danoff BF, McDay J, Louka M, Lewis GC, Lee J, Kramer S. Stage III endometrial carcinoma: analysis of patterns of failure and therapeutic implications. Int. J. Radiat. Oncol. Biol. Phys. 6(11 , 1491-1495 (1980).
44. Genest P, Drouin P, Girard A, Gerig L. Stage III carcinoma of the endometrium: a review of 41 cases. Gynecol. Oncol. 26(1), 77-86 (1987).
45. Bruckman JE, BloomerWD, Marck A, Ehrmann RL, Knapp RC. Stage III adenocarcinoma of the endometrium: two prognostic groups. Gynecol. Oncol. 9(1), 12-17 (1980).
46. Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol. Oncol. 17(1), 85-103 (1984).
47. Goff BA, Goodman A, Muntz HG, Fuller AF Jr, Nikrui N, Rice LW. Surgical Stage IV endometrial carcinoma: a study of 47 cases. Gynecol. Oncol. 52(2), 237-240 (1994).
48. Lambrou NC, Gomez-Marin O, Mirhashemi R et al. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol. Oncol. 93(3), 653-658 (2004).
49. Chi DS, Welshinger M, Venkatraman ES, Barakat RR. The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol. Oncol. 67(1), 56-60 (1997).
50. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Moritz FJ. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol. Oncol. 78(2), 85-91 (2000).
51. Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C, Gershenson DM. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol. Oncol. 59(2), 221-225 (1995).
52. Kuten A, Grigsby PW, Perez CA, Fineberg B, Garcia DM, Simpson JR. Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients. Int. J. Radiat. Oncol. Biol. Phys. 17(1), 29-34 (1989).
53. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma: a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1, 1777 (1948).
54. Chi DS, Gemignani ML, Curtin JP, Hoskins WJ. Long-term experience in the surgical management of cancer of the uterine cervix. Semin. Surg. Oncol. 17(3), 161-167 (1999).
55. Morris M, Alvarez RD, Kinney WK, Wilson TO. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol. Oncol. 60(2), 288-291 (1996).
56. Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP. Pelvic exenteration for recurrent endometrial cancer. Gynecol. Oncol. 75(1), 99-102 (1999).
57. Garton GR, Gunderson LL, Webb MJ et al. Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience. Gynecol. Oncol. 48(3), 328-332 (1993).
58. Garton GR, Gunderson LL, Webb MJ, Wilson TO, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution. Int. J. Radiat. Oncol. Biol. Phys. 37(4), 839-843 (1997).
59. Haddock MG, Petersen IA, Webb MJ, Wilson TO, Podratz KC, Gunderson LL. IORT for locally advanced gynecological malignancies. Front. Radiat. Ther. Oncol. 31, 256-259 (1997).
60. Gemignani ML, Alektiar KM, Leitao M et al. Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int. J. Radiat. Oncol. Biol. Phys. 50(3), 687-694 (2001).
61. Campagnutta E, Giorda G, De Piero G et al. Surgical treatment of recurrent endometrial carcinoma. Cancer 100(1), 89-96 (2004).